Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease.

Sci Rep · 2021 · PMC8481560 · PMID 34588601

Europe PMC DOI

hedged sentence

0.0850

closest p · 1.7× alpha

0.0850

boldest claim

The sentences

of borderline significancep = 0.085so close (0.05 < p ≤ 0.1)

In terms of symptomatic cerebral hemorrhage, the potency of antiplatelet agents was insignificant (Supplementary Table 3 ), and the duration of medication was of borderline significance (adjusted HR 0.99; 95% CI 0.97–0.100; p = 0.085).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.